Apoxis S. A.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Apoxis S. A..The latest application filed is for "method for the administration of ligands, agonists of ligands of the tnf family with reduced toxicity".

Company Profile

0.7.10

Apoxis S. A. - Epalinges CH
Apoxis SA -
Apoxis SA - Epalinges CH
APOXIS SA - Lausanne CH
Apoxis SA - Epalingee CH

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks

Patent Activity

Patent	Date
Method For The Administration Of Ligands, Agonists Of Ligands Of The Tnf Family With Reduced Toxicity App 20130344025 - Rosat; Jean-Pierre	2013-12-26
Baff Receptor (bcma), An Immunoregulatory Agent App 20120214687 - Jeffrey; Browning ; et al.	2012-08-23
Taci As An Anti-tumor Agent App 20120189634 - Ambrose; Christine ; et al.	2012-07-26
Method For The Administration Of Ligands, Agonists Of Ligands Of The Tnf Family With Reduced Toxicity App 20120015889 - Rosat; Jean-Pierre	2012-01-19
Antibodies to train R: a cysteine-rich member of the TNF-receptor family, and methods of treating tumors expressing said receptor Grant 7,838,639 - Tschopp , et al. November 23, 2	2010-11-23
Fusion Constructs Containing Active Sections Of Tnf Ligands App 20100254984 - Gaide; Olivier ; et al.	2010-10-07
Fusion constructs containing active sections on TNF ligands Grant 7,736,657 - Gaide , et al. June 15, 2	2010-06-15
BAFF receptor (BCMA), an immunoregulatory agent Grant 7,691,804 - Jeffrey , et al. April 6, 2	2010-04-06
Baff Receptor (bcma), An Immunoregulatory Agent App 20100040627 - Jeffrey; Browning ; et al.	2010-02-18
Method For The Administration Of Ligands, Agonists Of Ligands Of The Tnf Family With Reduced Toxicity App 20100009918 - Rosat; Jean-Pierre	2010-01-14
Method For The Treatment Of Gout Or Pseudogout App 20090022704 - Petrilli; Virginie ; et al.	2009-01-22
TRAIN-R: a cysteine-rich member of the TNF-receptor family Grant 7,402,658 - Tschopp , et al. July 22, 2	2008-07-22
Method to Reduce Hepatoxicity of Fas-Mediated Apoptosis-Inducing Agents App 20080003226 - Dupuis; Marc ; et al.	2008-01-03
Methods of treating a tumor that expresses APRIL by administering BCMA Grant 7,276,241 - Schneider , et al. October 2, 2	2007-10-02
Method For The Treatment Of Gout Or Pseudogout App 20070161559 - Petrilli; Virginie ; et al.	2007-07-12
Nucleic acids encoding TRAIN-R: a cysteine rich member of the TNF-receptor family Grant 7,223,852 - Tschopp , et al. May 29, 2	2007-05-29
Methods of treatment by administering an anti-BCMA antibody Grant 7,083,785 - Browning , et al. August 1, 2	2006-08-01

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.